phosphorylethanolamine has been researched along with Atherogenesis in 2 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ding, L | 1 |
Zhang, LY | 1 |
Shi, HH | 1 |
Wang, CC | 1 |
Jiang, XM | 1 |
Xue, CH | 1 |
Yanagita, T | 1 |
Zhang, TT | 1 |
Wang, YM | 1 |
Singh, SK | 1 |
Suresh, MV | 1 |
Prayther, DC | 1 |
Moorman, JP | 1 |
RusiƱol, AE | 1 |
Agrawal, A | 1 |
2 other studies available for phosphorylethanolamine and Atherogenesis
Article | Year |
---|---|
Eicosapentaenoic Acid-Enriched Phosphoethanolamine Plasmalogens Alleviated Atherosclerosis by Remodeling Gut Microbiota to Regulate Bile Acid Metabolism in LDLR
Topics: Animals; Atherosclerosis; Bile Acids and Salts; Cholesterol 7-alpha-Hydroxylase; Eicosapentaenoic Ac | 2020 |
C-reactive protein-bound enzymatically modified low-density lipoprotein does not transform macrophages into foam cells.
Topics: Atherosclerosis; Binding Sites; C-Reactive Protein; Cells, Cultured; Centrifugation, Density Gradien | 2008 |